184 related articles for article (PubMed ID: 30781765)
1. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.
Yang JYC; Verleden SE; Zarinsefat A; Vanaudenaerde BM; Vos R; Verleden GM; Sarwal RD; Sigdel TK; Liberto JM; Damm I; Watson D; Sarwal MM
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30781765
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
3. Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.
Shino MY; Todd JL; Neely ML; Kirchner J; Frankel CW; Snyder LD; Pavlisko EN; Fishbein GA; Schaenman JM; Mason K; Kesler K; Martinu T; Singer LG; Tsuang W; Budev M; Shah PD; Reynolds JM; Williams N; Robien MA; Palmer SM; Weigt SS; Belperio JA
Am J Transplant; 2022 Sep; 22(9):2169-2179. PubMed ID: 35634722
[TBL] [Abstract][Full Text] [Related]
4. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
[TBL] [Abstract][Full Text] [Related]
5. Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant.
Rosenheck JP; Ross DJ; Botros M; Wong A; Sternberg J; Chen YA; Liang N; Baer A; Ahmed E; Swenerton R; Zimmermann BG; Fehringer G; Demko ZP; Olymbios M; Billings PR; Keller BC
Transplant Direct; 2022 Apr; 8(4):e1317. PubMed ID: 35372675
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
[TBL] [Abstract][Full Text] [Related]
7. Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients.
Ju C; Xu X; Zhang J; Chen A; Lian Q; Liu F; Liu H; Cai Y; Zou Y; Yang Y; Zhou Y; He J
BMC Pulm Med; 2023 Jan; 23(1):37. PubMed ID: 36703125
[TBL] [Abstract][Full Text] [Related]
8. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
Front Immunol; 2021; 12():661761. PubMed ID: 34122421
[TBL] [Abstract][Full Text] [Related]
9. Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR.
Sigdel TK; Archila FA; Constantin T; Prins SA; Liberto J; Damm I; Towfighi P; Navarro S; Kirkizlar E; Demko ZP; Ryan A; Sigurjonsson S; Sarwal RD; Hseish SC; Chan-On C; Zimmermann B; Billings PR; Moshkevich S; Sarwal MM
J Clin Med; 2018 Dec; 8(1):. PubMed ID: 30583588
[TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
11. The common rejection module in chronic rejection post lung transplantation.
Sacreas A; Yang JYC; Vanaudenaerde BM; Sigdel TK; Liberto JM; Damm I; Verleden GM; Vos R; Verleden SE; Sarwal MM
PLoS One; 2018; 13(10):e0205107. PubMed ID: 30289917
[TBL] [Abstract][Full Text] [Related]
12. New Clue: Prediction from Cell-Free DNA.
Sanders YY
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708076
[TBL] [Abstract][Full Text] [Related]
13. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A;
Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829
[TBL] [Abstract][Full Text] [Related]
14. Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.
Keller MB; Tian X; Jang MK; Meda R; Charya A; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S
Am J Respir Crit Care Med; 2024 May; 209(10):1238-1245. PubMed ID: 38190701
[No Abstract] [Full Text] [Related]
15. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
16. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
17. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
18. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
[TBL] [Abstract][Full Text] [Related]
19. Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction.
Saito T; Liu M; Binnie M; Sato M; Hwang D; Azad S; Machuca TN; Zamel R; Waddell TK; Cypel M; Keshavjee S
Am J Transplant; 2014 Jun; 14(6):1425-32. PubMed ID: 24787265
[TBL] [Abstract][Full Text] [Related]
20. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
